Epigallocatechin-3-gallate, an active ingredient of Traditional Chinese Medicines, inhibits the 3CLpro activity of SARS-CoV-2
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Epigallocatechin-3-gallate, an active ingredient of Traditional Chinese Medicines, inhibits the 3CLpro activity of SARS-CoV-2
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
Volume 176, Issue -, Pages 1-12
Publisher
Elsevier BV
Online
2021-02-05
DOI
10.1016/j.ijbiomac.2021.02.012
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health — The latest 2019 novel coronavirus outbreak in Wuhan, China
- (2020) David S. Hui et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
- (2020) Roujian Lu et al. LANCET
- A pneumonia outbreak associated with a new coronavirus of probable bat origin
- (2020) Peng Zhou et al. NATURE
- Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia
- (2020) Qun Li et al. NEW ENGLAND JOURNAL OF MEDICINE
- The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2
- (2020) Nature Microbiology
- Nature-derived compounds modulating Wnt/β-catenin pathway: a preventive and therapeutic opportunity in neoplastic diseases
- (2020) G. Sferrazza et al. Acta Pharmaceutica Sinica B
- Becoming a Faithful Defender: Traditional Chinese Medicine against Coronavirus Disease 2019 (COVID-19)
- (2020) Leyin Zhang et al. AMERICAN JOURNAL OF CHINESE MEDICINE
- Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors
- (2020) Zhenming Jin et al. NATURE
- A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
- (2020) Bin Cao et al. NEW ENGLAND JOURNAL OF MEDICINE
- Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors
- (2020) Linlin Zhang et al. SCIENCE
- Structural stability of SARS-CoV-2 3CLpro and identification of quercetin as an inhibitor by experimental screening
- (2020) Olga Abian et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Protective Effect of Epigallocatechin-3-Gallate (EGCG) in Diseases with Uncontrolled Immune Activation: Could Such a Scenario Be Helpful to Counteract COVID-19?
- (2020) Marta Menegazzi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Potential Therapeutic Targets of Epigallocatechin Gallate (EGCG), the Most Abundant Catechin in Green Tea, and Its Role in the Therapy of Various Types of Cancer
- (2020) Saleh A. Almatroodi et al. MOLECULES
- Chemical composition and pharmacological mechanism of Qingfei Paidu Decoction and Ma Xing Shi Gan Decoction against Coronavirus Disease 2019 (COVID-19): In silico and experimental study
- (2020) Ruocong Yang et al. PHARMACOLOGICAL RESEARCH
- The clinical benefits of Chinese patent medicines against COVID-19 based on current evidence
- (2020) Dan Zhang et al. PHARMACOLOGICAL RESEARCH
- Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2)
- (2020) Li Runfeng et al. PHARMACOLOGICAL RESEARCH
- Bioactive natural compounds against human coronaviruses: a review and perspective
- (2020) Yanfang Xian et al. Acta Pharmaceutica Sinica B
- Accelerated preclinical paths to support rapid development of COVID-19 therapeutics
- (2020) Jay A. Grobler et al. Cell Host & Microbe
- Roles of flavonoids against coronavirus infection
- (2020) Maria Russo et al. CHEMICO-BIOLOGICAL INTERACTIONS
- COVID-19 update: The race to therapeutic development
- (2020) Julianne D. Twomey et al. DRUG RESISTANCE UPDATES
- Tea Polyphenols EGCG and Theaflavin Inhibit the Activity of SARS-CoV-2 3CL-Protease In Vitro
- (2020) Minsu Jang et al. Evidence-based Complementary and Alternative Medicine
- A pragmatic randomized controlled trial reports lack of efficacy of hydroxychloroquine on coronavirus disease 2019 viral kinetics
- (2020) Magnus Nakrem Lyngbakken et al. Nature Communications
- Current Prevention of COVID-19: Natural Products and Herbal Medicine
- (2020) Junqing Huang et al. Frontiers in Pharmacology
- Efficacy of Early Combination Therapy With Lianhuaqingwen and Arbidol in Moderate and Severe COVID-19 Patients: A Retrospective Cohort Study
- (2020) Jie Fang et al. Frontiers in Pharmacology
- Cytokine elevation in severe and critical COVID-19: a rapid systematic review, meta-analysis, and comparison with other inflammatory syndromes
- (2020) Daniel E Leisman et al. Lancet Respiratory Medicine
- Identifying potential anti-COVID-19 pharmacological components of traditional Chinese medicine Lianhuaqingwen capsule based on human exposure and ACE2 biochromatography screening
- (2020) Xiaofei Chen et al. Acta Pharmaceutica Sinica B
- Recent Advances in the Understanding of the Health Benefits and Molecular Mechanisms Associated with Green Tea Polyphenols
- (2019) Lujuan Xing et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
- Ultra-large library docking for discovering new chemotypes
- (2019) Jiankun Lyu et al. NATURE
- Protective effect of green tea catechin against urban fine dust particle-induced skin aging by regulation of NF-κB, AP-1, and MAPKs signaling pathways
- (2019) Lei Wang et al. ENVIRONMENTAL POLLUTION
- Antiviral potential of medicinal plants against HIV, HSV, influenza, hepatitis, and coxsackievirus: A systematic review
- (2018) Muhammad Akram et al. PHYTOTHERAPY RESEARCH
- An Overview of Severe Acute Respiratory Syndrome–Coronavirus (SARS-CoV) 3CL Protease Inhibitors: Peptidomimetics and Small Molecule Chemotherapy
- (2016) Thanigaimalai Pillaiyar et al. JOURNAL OF MEDICINAL CHEMISTRY
- Looking for protein stabilizing drugs with thermal shift assay
- (2015) Giuseppina Andreotti et al. Drug Testing and Analysis
- Effect of Lianhuaqingwen Capsules on Airway Inflammation in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease
- (2014) Liang Dong et al. Evidence-based Complementary and Alternative Medicine
- From SARS to MERS: crystallographic studies on coronaviral proteases enable antiviral drug design
- (2014) Rolf Hilgenfeld FEBS Journal
- Direct interaction of natural and synthetic catechins with signal transducer activator of transcription 1 affects both its phosphorylation and activity
- (2013) Marta Menegazzi et al. FEBS Journal
- The newly emerged SARS-Like coronavirus HCoV-EMC also has an “Achilles’ heel”: current effective inhibitor targeting a 3C-like protease
- (2013) Zhilin Ren et al. Protein & Cell
- Flavonoid-mediated inhibition of SARS coronavirus 3C-like protease expressed in Pichia pastoris
- (2012) Thi Thanh Hanh Nguyen et al. BIOTECHNOLOGY LETTERS
- Activation and maturation of SARS-CoV main protease
- (2011) Bin Xia et al. Protein & Cell
- Biflavonoids from Torreya nucifera displaying SARS-CoV 3CLpro inhibition
- (2010) Young Bae Ryu et al. BIOORGANIC & MEDICINAL CHEMISTRY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search